| Ytd | 31.06% | |
| 1y | 1797.85% |
| Open | 52.97 | Prev Close | 52.95 | Low | 52.95 | High | 52.97 | Mkt Cap | 4.77B |
| Vol | 6.33M | Avg Vol | 4.84M | EPS | -1.03 | P/E | -51.41 | Forward P/E | -34.01 |
| Beta | -0.38 | Short Ratio | 0.70 | Inst. Own | 109.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-07 | 50-d Avg | 50.15 | 200-d Avg | 29.48 | 1yr Est | 53.00 |
TERN News
Tern PLC (AIM:TERN) shares surged some 30% higher, to 1.18p, after it increased exposure to Talking
https://www.bloomberg.com/news/articles/2026-05-18/merck-starts-seven-part-high-grade-bond-sale-to-f
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Cana
Merck retains a 'strong buy' rating, driven by proactive oncology pipeline expansion to offset KEYTR
Merck MRK is set to report its first-quarter 2026 earnings on April 30, before market open. The Zac
Designation for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloi
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Cana
Inhibrx explores spin-off of INBRX-106 amid Big Pharma interest, with potential valuation exceeding
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan
All told, the transaction is valued at around $6.7 billion. If all goes well, it'll close this quart
The deal consideration is $53.00 per share in cash for an approximate equity value of $6.7 billion.
Merck begins tender offer for Terns at $53 per share as part of its planned acquisition announced in
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Cana
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Terns (NASDAQ: TERN) for po
Capricorn Fund Managers Ltd bought a new stake in shares of Terns Pharmaceuticals, Inc. (NASDAQ: TER
FOSTER CITY, Calif., April 02, 2026 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the
Pre-Market Stock Futures: Futures are trading higher this morning after reports are circulating that
Top Wall Street analysts changed outlook on top names. For all changes, including upgrades/downgrade
Pre-Market Stock Futures: Futures are trading lower as we prepare to end another up-and-down week, a
MRK's $6.7B Terns buyout is set to add a promising leukemia drug candidate, boosting its oncology pi
Wall Street analysts changed outlook on top names. See full changes on analyst ratings page. UNFI st
Wall Street analysts changed outlook on top names. View all changes on analyst ratings page. See wha
E. Ohman J or Asset Management AB lessened its position in shares of Terns Pharmaceuticals, Inc. (NA
Shares of Terns Pharmaceuticals, Inc. (NASDAQ: TERN - Get Free Report) reached a new 52-week high du
Wall Street analysts changed their outlook on top names. Check analyst ratings page for upgrades, do
Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure
https://www.bloomberg.com/news/articles/2024-12-13/ozempic-craze-appears-to-be-curbing-us-obesity-ep
https://www.medscape.com/viewarticle/ada-advises-against-using-compounded-glp-1-ra-medications-2024a
https://www.statnews.com/2024/10/30/novo-nordisk-ozempic-wegovy-fda-available-or-in-shortage/
Eli Lilly and Novo Nordisk face selloff as new weight-loss drugs threaten dominance. Shares of both
Shares of Take-Two Interactive Software, Inc. (NASDAQ: TTWO) fell sharply during Friday’s session
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the compa
U.S. stocks traded lower, with the Dow Jones index falling more than 100 points on Monday.